Data for ST003364
Metabolite structure | All data | F1 | F2 | F3 | F4 | F5 | F6 | F7 | F8 | F9 | F10 | F11 | F12 | F13 | F14 | F15 | F16 | F17 | F18 | F19 | F20 | F21 | F22 | F23 | F24 | F25 | F26 | F27 | F28 | F29 | F30 | F31 | F32 | F33 | F34 | F35 | F36 | F37 | F38 | F39 | F40 | F41 | F42 | F43 | F44 | F45 | F46 | F47 | F48 | F49 | F50 | F51 | F52 | F53 | F54 | F55 | F56 | F57 | F58 | F59 | F60 | F61 | F62 | F63 | F64 | F65 | F66 | F67 | F68 | F69 | F70 | F71 | F72 | F73 | F74 | F75 | F76 | F77 | F78 | F79 | F80 | F81 | F82 | F83 | F84 | F85 | F86 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
LPA 18:1 | 95174813.67 | 52181136.86 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PA 17:0_17:0 | 34991508.43 | 30866041.95 |
Factors:
F1 | Sample source:Aortic valve tissue | Analysis method:acidified MeOH/CHCl3 extraction and targeted SRM | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed |
F2 | Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed |
F3 | Sample source:Aortic valve tissue | Analysis method:Assessment of PA and LPA recovery rates | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F4 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS10 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F5 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS11 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F6 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS12 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F7 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS13 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F8 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS14 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F9 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS15 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F10 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS16 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F11 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS17 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F12 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS18 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F13 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS19 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F14 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS1 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F15 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS20 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F16 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS21 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F17 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS22 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F18 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS23 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F19 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS24 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F20 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS25 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F21 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS26 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F22 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS27 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F23 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS28 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F24 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS29 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F25 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS2 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F26 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS30 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F27 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS31 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F28 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS32 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F29 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS33 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F30 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS34 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F31 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS35 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F32 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS36 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F33 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS37 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F34 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS38 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F35 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS39 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F36 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS3 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F37 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS40 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F38 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS41 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F39 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS42 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F40 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS43 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F41 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS44 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F42 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS4 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F43 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS5 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F44 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS6 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F45 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS7 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F46 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS8 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F47 | Sample source:Aortic valve tissue | Analysis method:Folch extraction and untargeted MS9 | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F48 | Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:BAV | Sex:female | Pathology:calcific |
F49 | Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:BAV | Sex:female | Pathology:fibrotic |
F50 | Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:BAV | Sex:female | Pathology:mildly diseased |
F51 | Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:BAV | Sex:male | Pathology:fibrotic |
F52 | Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:BAV | Sex:male | Pathology:mildly diseased |
F53 | Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:mixed | Sex:mixed | Pathology:mixed |
F54 | Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:female | Pathology:calcific |
F55 | Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:female | Pathology:fibrotic |
F56 | Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:female | Pathology:mildly diseased |
F57 | Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:male | Pathology:calcific |
F58 | Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:male | Pathology:fibrotic |
F59 | Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:acidified MeOH/CHCl3 | Morphology:TAV | Sex:male | Pathology:mildly diseased |
F60 | Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:calcific |
F61 | Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:fibrotic |
F62 | Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:mildly diseased |
F63 | Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:calcific |
F64 | Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:fibrotic |
F65 | Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:mildly diseased |
F66 | Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F67 | Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:calcific |
F68 | Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:fibrotic |
F69 | Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:mildly diseased |
F70 | Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:calcific |
F71 | Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:fibrotic |
F72 | Sample source:Aortic valve tissue | Analysis method:Targeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:mildly diseased |
F73 | Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids identification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F74 | Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:calcific |
F75 | Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:fibrotic |
F76 | Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:female | Pathology:mildly diseased |
F77 | Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:calcific |
F78 | Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:fibrotic |
F79 | Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:BAV | Sex:male | Pathology:mildly diseased |
F80 | Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:mixed | Sex:mixed | Pathology:mixed |
F81 | Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:calcific |
F82 | Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:fibrotic |
F83 | Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:female | Pathology:mildly diseased |
F84 | Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:calcific |
F85 | Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:fibrotic |
F86 | Sample source:Aortic valve tissue | Analysis method:Untargeted lipidomics for human AV lipids quantification | Extraction method:Folch | Morphology:TAV | Sex:male | Pathology:mildly diseased |